Colchicine may be used with caution to manage flare-ups of crystal-induced arthritis among patients with severe chronic kidney disease, with dosage modifications and careful monitoring required.

Colchicine use is associated with a modest reduction in the long-term risk for total joint arthroplasty (TJA) among individuals with gout, according to study findings published in Arthritis & ...

The media reports that colchicine, a very old drug, has now been discovered to reduce the risk of recurrent heart disease and has a new FDA indication. Of course, the “discovery” has taken 10 years, ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — The use of colchicine for gout flare prevention imparts a “modest” decrease in the risk for knee or ...

(Boston)—Gout is the most common form of inflammatory arthritis, with worldwide prevalence of approximately four%. The accumulation of monosodium urate crystals in gout leads to the clinical ...

A recent review found that low dose colchicine may help prevent heart attacks and strokes in individuals who already have cardiovascular disease. The review also found that colchicine likely doesn’t ...

WASHINGTON, DC – OCTOBER 29, 2024 – The largest trial to examine the impact of colchicine in acute myocardial infarction (MI) found that both acute and long-term colchicine use did not reduce ...

Please provide your email address to receive an email when new articles are posted on . “Therefore, it is very important for patients and clinicians alike to be aware of the cardiovascular safety of ...

Credit: Getty Images Researchers compared rates of gout medication initiation among patients with gout and type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists. The use of ...